446 related articles for article (PubMed ID: 23274118)
21. [Phytoestrogens].
Zittermann A
Zentralbl Gynakol; 2003 Jun; 125(6):195-201. PubMed ID: 14556117
[TBL] [Abstract][Full Text] [Related]
22. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
[TBL] [Abstract][Full Text] [Related]
23. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
24. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
Sakamoto T; Horiguchi H; Oguma E; Kayama F
J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
[TBL] [Abstract][Full Text] [Related]
25. Implications of phytoestrogen intake for breast cancer.
Duffy C; Perez K; Partridge A
CA Cancer J Clin; 2007; 57(5):260-77. PubMed ID: 17855484
[TBL] [Abstract][Full Text] [Related]
26. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
[TBL] [Abstract][Full Text] [Related]
27. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
Zava DT; Duwe G
Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
[TBL] [Abstract][Full Text] [Related]
28. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
Suetsugi M; Su L; Karlsberg K; Yuan YC; Chen S
Mol Cancer Res; 2003 Nov; 1(13):981-91. PubMed ID: 14638870
[TBL] [Abstract][Full Text] [Related]
29. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling.
Molina L; Bustamante FA; Bhoola KD; Figueroa CD; Ehrenfeld P
Clin Sci (Lond); 2018 Dec; 132(24):2583-2598. PubMed ID: 30545896
[TBL] [Abstract][Full Text] [Related]
30. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
[TBL] [Abstract][Full Text] [Related]
31. Phytoestrogens as cardioprotective agents.
Park D; Huang T; Frishman WH
Cardiol Rev; 2005; 13(1):13-7. PubMed ID: 15596022
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition of human breast cancer cells by herbs and phytoestrogens.
Dixon-Shanies D; Shaikh N
Oncol Rep; 1999; 6(6):1383-7. PubMed ID: 10523716
[TBL] [Abstract][Full Text] [Related]
33. Development of QSAR models to predict estrogenic, carcinogenic, and cancer protective effects of phytoestrogens.
Singh AK
Cancer Invest; 2001; 19(2):201-16. PubMed ID: 11296624
[TBL] [Abstract][Full Text] [Related]
34. A new class of phytoestrogens; evaluation of the estrogenic activity of deoxybenzoins.
Fokialakis N; Lambrinidis G; Mitsiou DJ; Aligiannis N; Mitakou S; Skaltsounis AL; Pratsinis H; Mikros E; Alexis MN
Chem Biol; 2004 Mar; 11(3):397-406. PubMed ID: 15123269
[TBL] [Abstract][Full Text] [Related]
35. Isoflavones and women's health.
Powles T
Breast Cancer Res; 2004; 6(3):140-2. PubMed ID: 15084236
[TBL] [Abstract][Full Text] [Related]
36. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
[TBL] [Abstract][Full Text] [Related]
37. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
[TBL] [Abstract][Full Text] [Related]
38. [Phytoestrogens and SERMS, alternatives to classical hormone therapy?].
Huber J
Ther Umsch; 2000 Oct; 57(10):651-4. PubMed ID: 11081378
[TBL] [Abstract][Full Text] [Related]
39. Global gene expression profiles induced by phytoestrogens in human breast cancer cells.
Dip R; Lenz S; Antignac JP; Le Bizec B; Gmuender H; Naegeli H
Endocr Relat Cancer; 2008 Mar; 15(1):161-73. PubMed ID: 18310284
[TBL] [Abstract][Full Text] [Related]
40. Developing phytoestrogens for breast cancer prevention.
Liu MM; Huang Y; Wang J
Anticancer Agents Med Chem; 2012 Dec; 12(10):1306-13. PubMed ID: 22583409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
